CD Antigens

Research Areas

Products Related to CD Antigens(104)

GC83418 Linclatamig
CAS: 2885203-43-8
Purity: >97.00%
Linclatamig (BLYG8824A) is a humanized IgG1 T-cell engaging bispecific antibody (TCB) targeting LY6G6D and CD3.
GC83583 Mipletamig
CAS: 2839556-21-5
Purity: >99.00%
Mipletamig (APVO-436) is a bispecific CD123 x CD3 monoclonal antibody.
GC83692 Nebratamig
CAS: 2694723-68-5
Purity: >97.00%
Nebratamig (GNC-035) is an anti- ROR1 /anti- CD3 /anti- PD-L1 /anti- 4-1BB tetra-specific antibody with potential immunostimulatory and antineoplastic activities [1] .
GC83746 Obrixtamig
CAS: 2851943-09-2
Purity: >99.50%
Obrixtamig (BI 764532; OBT 620) is an CD3E/DLL3 -targeting L-κ-G1-h-CH2-CH3_L-λ-G1-h-CH2-CH3 type human antibody.
GC83806 Pasritamig
CAS: 2921676-04-0
Purity: >99.50%
Pasritamig (JNJ-78278343; KLCB-245) is a bispecific T-cell engager ( BiTE ) that targets the complex of human kallikrein KLK2 and CD3 receptor.
GC83817 Peluntamig
CAS: 2928515-21-1
Purity: >99.50%
Peluntamig (PT-217) is a bispecific antibody targeting DLL3 and CD47.
GC83854 PKHB1
CAS: 1505523-99-8
Purity: >99.50%
PKHB1 (txCD47) is a CD47 agonist and Thrombospondin-1 peptide mimetic.
GC83950 Ramantamig
CAS: 2988886-91-3
Purity: >95.00%
Ramantamig (JNJ-79635322) is a humanized monoclonal antibody targeting human CD3ε, GPRC5D, and TNFRSF17 (BCMA).
GC83967 RG-6333
Purity: >98.00%
RG-6333 is a bispecific agonist targeting CD19 and CD28.
GC84036 Safimestomig
CAS: 2911590-72-0
Purity: >99.00%
Safimestomig (6MW3211) is an CD47/PD-L1 -targeting bispecific antibody.
GC84043 SAR-442257
Purity: >99.00%
SAR-442257 is a trispecific T-cell engager and monoclonal antibody that binds to CD38, CD3 and CD28.
GC84123 Spevatamig
CAS: 2928515-36-8
Purity: >99.00%
is an CD47/CLDN18 -targeting (H-γ1_L-κ)_(H-γ1_L-κ) type bispecific antibody [1] .
GC84133 STI-6643
CAS: 2376730-61-7
Purity: >99.50%
STI-6643 is a fully human IgG4 antibody that targets CD47.
GC84149 Surovatamig
CAS: 2892667-02-4
Purity: >99.50%
Surovatamig (AZD0486; TNB-486) is a fully human anti- CD19 / CD3 IgG4 bispecific antibody.
GC84298 Trevotamig
CAS: 2920215-79-6
Purity: >95.50%
is an EPCAM/CD3E -targeting H-γ1_L-κ-scFvhl dimer type bispecific antibody [1] .
GC84339 Ubletamig
CAS: 3008247-27-3
Purity: >98.00%
Ubletamig is an anti- MUC16 human IgG4 κ monoclonal antibody.
GC84462 ZLIRTLHEWY
Purity: >99.00%
ZLIRTLHEWY is a potent peptide CD47/SIRPα interaction inhibitor.
GC84465 Zubotamig
CAS: 2640279-10-1
Purity: >96.00%
Zubotamig (Gen1047) is an CD3E/VTCN1-targeting Ig(G1 -κ_G1 -λ2) type chimeric human antibody.
GC84567 CD19 CAR mRNA (Human)
CD19 CAR mRNA (Human) expresses CAR protein that specifically targets human CD19.
GC84604 Runimotamab
CAS: 2361325-98-4
Purity: >99.00%
Runimotamab (BTRC-4017A) is a HER2 and CD3 T cell-engaging bispecific antibody.
GC84635 Anti-Mouse/Rat/Human CD47/IAP Antibody (MIAP410)
Purity: >99.50%
Anti-Mouse/Rat/Human CD47/IAP Antibody (MIAP410) is an anti-mouse/rat/human CD47/IAP IgG1 monoclonal antibody.
GC84638 Anti-CD3 Antibody (OKT-3)
Purity: >97.50%
Anti-CD3 Antibody (OKT-3) is a kind of mouse IgG2a κ antibody inhibitor, targeting to human CD3.
GC84639 Erzotabart
CAS: 2430792-01-9
Purity: >99.00%
Erzotabart is an IgG1-kappa, anti- CD38 (ADP-ribosyl cyclase 1, cyclic ADP-ribose hydrolase 1, cADPr hydrolase 1, cADPR1) Homo sapiens monoclonal antibody.
GC84672 Xaluritamig
CAS: 2559056-68-5
Purity: >99.00%
Xaluritamig (AMG-509) is a bispecific T cell engager and cytolytic agent with a K d of 27.6 nM for human CD3ε. Xaluritamig binds to CD3ε via an anti- CD3 single-chain variable fragment ( scFv ) domain, and to STEAP1 via a bispecific anti- STEAP1 antigen-binding fragment (Fab) domain, thereby recruiting and activating T cells and forming a bridge between T cells and STEAP1 -expressing cancer cells.

Category Product List
Catalog No.	Product Name	CAS No.	Purity
GC83418	Linclatamig	2885203-43-8	>97.00%
GC83418	Linclatamig (BLYG8824A) is a humanized IgG1 T-cell engaging bispecific antibody (TCB) targeting LY6G6D and CD3.
GC83583	Mipletamig	2839556-21-5	>99.00%
GC83583	Mipletamig (APVO-436) is a bispecific CD123 x CD3 monoclonal antibody.
GC83692	Nebratamig	2694723-68-5	>97.00%
GC83692	Nebratamig (GNC-035) is an anti- ROR1 /anti- CD3 /anti- PD-L1 /anti- 4-1BB tetra-specific antibody with potential immunostimulatory and antineoplastic activities [1] .
GC83746	Obrixtamig	2851943-09-2	>99.50%
GC83746	Obrixtamig (BI 764532; OBT 620) is an CD3E/DLL3 -targeting L-κ-G1-h-CH2-CH3_L-λ-G1-h-CH2-CH3 type human antibody.
GC83806	Pasritamig	2921676-04-0	>99.50%
GC83806	Pasritamig (JNJ-78278343; KLCB-245) is a bispecific T-cell engager ( BiTE ) that targets the complex of human kallikrein KLK2 and CD3 receptor.
GC83817	Peluntamig	2928515-21-1	>99.50%
GC83817	Peluntamig (PT-217) is a bispecific antibody targeting DLL3 and CD47.
GC83854	PKHB1	1505523-99-8	>99.50%
GC83854	PKHB1 (txCD47) is a CD47 agonist and Thrombospondin-1 peptide mimetic.
GC83950	Ramantamig	2988886-91-3	>95.00%
GC83950	Ramantamig (JNJ-79635322) is a humanized monoclonal antibody targeting human CD3ε, GPRC5D, and TNFRSF17 (BCMA).
GC83967	RG-6333	-	>98.00%
GC83967	RG-6333 is a bispecific agonist targeting CD19 and CD28.
GC84036	Safimestomig	2911590-72-0	>99.00%
GC84036	Safimestomig (6MW3211) is an CD47/PD-L1 -targeting bispecific antibody.
GC84043	SAR-442257	-	>99.00%
GC84043	SAR-442257 is a trispecific T-cell engager and monoclonal antibody that binds to CD38, CD3 and CD28.
GC84123	Spevatamig	2928515-36-8	>99.00%
GC84123	is an CD47/CLDN18 -targeting (H-γ1_L-κ)_(H-γ1_L-κ) type bispecific antibody [1] .
GC84133	STI-6643	2376730-61-7	>99.50%
GC84133	STI-6643 is a fully human IgG4 antibody that targets CD47.
GC84149	Surovatamig	2892667-02-4	>99.50%
GC84149	Surovatamig (AZD0486; TNB-486) is a fully human anti- CD19 / CD3 IgG4 bispecific antibody.
GC84298	Trevotamig	2920215-79-6	>95.50%
GC84298	is an EPCAM/CD3E -targeting H-γ1_L-κ-scFvhl dimer type bispecific antibody [1] .
GC84339	Ubletamig	3008247-27-3	>98.00%
GC84339	Ubletamig is an anti- MUC16 human IgG4 κ monoclonal antibody.
GC84462	ZLIRTLHEWY	-	>99.00%
GC84462	ZLIRTLHEWY is a potent peptide CD47/SIRPα interaction inhibitor.
GC84465	Zubotamig	2640279-10-1	>96.00%
GC84465	Zubotamig (Gen1047) is an CD3E/VTCN1-targeting Ig(G1 -κ_G1 -λ2) type chimeric human antibody.
GC84567	CD19 CAR mRNA (Human)	-	-
GC84567	CD19 CAR mRNA (Human) expresses CAR protein that specifically targets human CD19.
GC84604	Runimotamab	2361325-98-4	>99.00%
GC84604	Runimotamab (BTRC-4017A) is a HER2 and CD3 T cell-engaging bispecific antibody.
GC84635	Anti-Mouse/Rat/Human CD47/IAP Antibody (MIAP410)	-	>99.50%
GC84635	Anti-Mouse/Rat/Human CD47/IAP Antibody (MIAP410) is an anti-mouse/rat/human CD47/IAP IgG1 monoclonal antibody.
GC84638	Anti-CD3 Antibody (OKT-3)	-	>97.50%
GC84638	Anti-CD3 Antibody (OKT-3) is a kind of mouse IgG2a κ antibody inhibitor, targeting to human CD3.
GC84639	Erzotabart	2430792-01-9	>99.00%
GC84639	Erzotabart is an IgG1-kappa, anti- CD38 (ADP-ribosyl cyclase 1, cyclic ADP-ribose hydrolase 1, cADPr hydrolase 1, cADPR1) Homo sapiens monoclonal antibody.
GC84672	Xaluritamig	2559056-68-5	>99.00%
GC84672	Xaluritamig (AMG-509) is a bispecific T cell engager and cytolytic agent with a K d of 27.6 nM for human CD3ε. Xaluritamig binds to CD3ε via an anti- CD3 single-chain variable fragment ( scFv ) domain, and to STEAP1 via a bispecific anti- STEAP1 antigen-binding fragment (Fab) domain, thereby recruiting and activating T cells and forming a bridge between T cells and STEAP1 -expressing cancer cells.